The Operating Unit of Clinical Medicine, in collaboration with the university, is an Internal Medicine Unit, equipped with 18 to 20 beds with possibility of monitoring telemetry ECG, blood pressure, respiratory rate and oxygen saturation.
The Unit deals with the conditions diagnosed by the internist from the emergency department, such as congestive heart failure, septic conditions, acute bronchopneumonia, and anemia.
Specialists in Internal Medicine, Cardiology, Clinical Immunology and Occupational Medicine, create the conditions pertaining to the management of systemic diseases with severe multiorgan involvement and the possibility for their causation.
The Unit specializes in two specific areas:
- Immunology: the main interests of the Operating Unit, in terms of clinical research, are aimed at diagnosis and treatment of:
- Autoimmune cytopenias (autoimmune anemia, autoimmune thrombocytopenia, autoimmune neutropenia).
- Vasculitis (Wegener, Churg-Strauss syndrome, micropolyangiitis, Polymyalgia rheumatica, Polyarteritis nodosa, Takayasu syndrome in Horton’s disease, cryoglobulinemia, vasculitis of the eye).
- Connective tissue (undifferentiated, mixed, systemic lupus erythematosus, Sjogren’s syndrome, polymyositis / dermatomyositis, antiphospholipid syndrome, relapsing polychondritis).
- Miscellaneous conditions (Behcet, Chronic urticaria and angioedema, Uveitis, hypereosinophilia, purpura).
- Cardiovascular area , specializing in the study (clinical research), diagnosis, management and treatment of syncope, blood pressure disorders and disorders of the autonomic nervous system that are associated with diabetes and neurodegenerative diseases such as Parkinson’s disease and Multiple System Atrophy. This area specializes in hospitalization, by monitoring inpatient beds along with the Syncope Unit. The latter consists of an outpatient clinic opened on hospital grounds, consisting of an emergency room and area for family doctors and labor settings, and a clinical laboratory that uses instruments for performing tilt tests, autonomic nervous system clinical trials, the measurement of catecholamines in plasma, 24 hour blood pressure monitoring and prolonged non-invasive ECG monitoring through “external loop recorders.”
The Syncope Unit also addresses issues related to the patient’s return to work after loss of consciousness. The aim is to reduce the time away from work and promote reintegration to adequately control and protect the health of workers and the community. The syncope unit is part of an international network of centers led by the National Dysautonomia Research Foundation, a nonprofit institution that aims to give support to patients with dysautonomia. The syncope unit ensures total clinical management of the patient with loss of consciousness, ranging from diagnosis to medical treatment and behavioral observation over time (follow-up).
Treatment activities are also carried out at the outpatient clinic and day hospital program (for infusion of biological drugs, immunoglobulins, etc.).